Patent · US Active

Compounds for modulating TRPV3 function

US8389546B2 · kind B2 · utility

2Cited by

11References

14Claims

0Family size

Assignee

Hydra Biosciences, LLC · US

Inventors

Magdalene M. Moran · Brookline, US
Jayhong A. Chong · Brookline, US
Christopher Fanger · Bolton, US
Amy Ripka · Reading, US
Glenn R. Larsen · Sudbury, US
Xiaoguang Zhen · New York, US
Dennis John Underwood · Brookline, US
Manfred Weigele · North Caldwell, US

Key dates

Filing date	Jul 1, 2011
Grant date	Mar 5, 2013
Priority date	—
Expiry date	Jul 1, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D401/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present application relates to compounds and methods for treating pain and other conditions related to TRPV3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.